Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme
Version of Record online: 27 APR 2011
© 2011 Blackwell Publishing Ltd
Volume 15, Issue 4, pages 433–440, December 2012
How to Cite
Anderson, C., Gifford, A., Avery, A., Fortnum, H., Murphy, E., Krska, J., Bond, C. and on behalf of the Yellow Card Study Collaboration (2012), Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme. Health Expectations, 15: 433–440. doi: 10.1111/j.1369-7625.2011.00686.x
- Issue online: 8 NOV 2012
- Version of Record online: 27 APR 2011
- Accepted for publication 23 March 2011
- 1Report of An Independent Review of Access to the Yellow Card Scheme. London: The Stationery Office, 2004..
- 2Medicines and Healthcare products Regulatory Agency (MHRA). What happens to a Yellow Card. Available at: http://www.mhra.gov.uk/Safetyinformation/Howwemonitorthesafetyofproducts/Medicines/TheYellowCardScheme/WhathappenstoaYellowCard/index.htm, accessed 9 June 2010.
- 3World Health Organisation. Consumer reporting of adverse drug reactions. WHO Drug Information, 2000; 14: 211–215.
- 12The Think Aloud Method. A Practical Guide to Modelling Cognitive Processes. London: Academic Press, 1994., , , .